Lavanya Sudharshan

Suggest Changes
Learn More
OBJECTIVES To evaluate the cost-effectiveness of first-line treatment of Overactive Bladder (OAB) with fesoterodine relative to mirabegron, from the Spanish National Health System (NHS) perspective.(More)
  • 1